Analyte sensor
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
1. An analyte sensor system, the system comprising:
a transcutaneous analyte sensor comprising:
an ex vivo portion configured to remain outside of a body of a host; and
an in vivo portion configured to be inserted into the body of the host, wherein the in vivo portion comprises:
an electrode; and
a membrane disposed over at least a portion of the electrode;
at least one processor configured to operably connect with the transcutaneous analyte sensor; and
a memory configured to operably connect with the at least one processor, the memory storing a calibration equation that includes a factor based at least in part on a measured characteristic of the membrane, wherein the factor is determined prior to insertion of the transcutaneous analyte sensor into the body of the host,
wherein the at least one processor is configured to calculate an analyte concentration by applying the calibration equation to data received from the transcutaneous analyte sensor.
2. The system of claim 1 wherein the at least one processor is physically connected with the transcutaneous analyte sensor.
3. The system of claim 1 wherein the at least one processor is wirelessly connected with the transcutaneous analyte sensor.
4. The system of claim 1 wherein the at least one processor comprises a first processor that is physically connected with the transcutaneous analyte sensor and a second processor that is wirelessly connected with the transcutaneous analyte sensor.
5. The system of claim 1 wherein the calibration equation is based at least in part on a predictive relationship between an in vitro sensitivity of the transcutaneous analyte sensor and an in vivo sensitivity of the transcutaneous analyte sensor.
6. The system of claim 1 wherein the calibration equation compensates for a drift in a sensitivity of the transcutaneous analyte sensor.
7. The system of claim 1 wherein the data received from the transcutaneous analyte sensor is configured to be calibrated via the calibration equation without a need for a reference analyte data obtained after insertion of the transcutaneous analyte sensor into the body of the host.
8. The system of claim 1 wherein the factor accommodates for a difference between a sensitivity of the transcutaneous analyte sensor due to the membrane and a sensitivity of at least one other analyte sensor.
9. The system of claim 1 wherein the measured characteristic of the membrane is a thickness of the membrane of the transcutaneous analyte sensor.
10. The system of claim 1 wherein the factor is determined by evaluating a signal response of the electrode to a non-bodily fluid.
11. The system of claim 1 wherein the factor or the calibration equation applied by the at least one processor is based on a calibration code.
12. The system of claim 1 wherein the membrane disposed over at least the portion of the electrode is a single layer membrane.
13. An analyte sensor system, the system comprising:
a transcutaneous analyte sensor comprising:
an ex vivo portion configured to remain outside of a body of a host; and
an in vivo portion configured to be inserted into the body of the host, wherein the in vivo portion comprises:
an electrode; and
a membrane disposed over at least a portion of the electrode;
at least one processor configured to operably connect with the transcutaneous analyte sensor; and
a memory configured to operably connect with the at least one processor, the memory storing a factor determined at least in part on a comparison between a measured membrane characteristic of the transcutaneous analyte sensor and a membrane characteristic of at least one other analyte sensor,
wherein the factor is determined prior to insertion of the transcutaneous analyte sensor into the body of the host,
wherein the at least one processor is configured to use the factor for calibrating sensor data.
14. The system of claim 13 , wherein the memory further stores a conversion function for calibrating the transcutaneous analyte sensor, the conversion function based at least in part on a predictive relationship between an in vitro sensitivity of the transcutaneous analyte sensor and an in vivo sensitivity of the transcutaneous analyte sensor, wherein the conversion function uses the factor.
15. The system of claim 14 , wherein the conversion function compensates for a drift in the in vivo sensitivity of the transcutaneous analyte sensor.
16. The system of claim 13 wherein the at least one processor is a single processor that is either physically connected with the transcutaneous analyte sensor or wirelessly connected with the transcutaneous analyte sensor.
17. The system of claim 13 , wherein the sensor data is configured to be calibrated without a need for a reference analyte data obtained after insertion of the transcutaneous analyte sensor into the body of the host.
18. The system of claim 13 wherein the measured membrane characteristic is a thickness of the membrane of the transcutaneous analyte sensor.
19. A method of monitoring an analyte, the method comprising:
beginning a sensor session associated with use of a transcutaneous analyte sensor, wherein the transcutaneous analyte sensor comprises:
an ex vivo portion configured to remain outside of a body of a host; and
an in vivo portion, wherein the in vivo portion comprises:
an electrode; and
a membrane disposed over at least a portion of the electrode;
storing a calibration equation associated with the transcutaneous analyte sensor in a memory, the calibration equation including a factor based at least in part on a measured characteristic of the membrane, wherein the factor is determined prior to insertion of the transcutaneous analyte sensor into the body of the host; and
processing, using at least one processor, data derived at least in part from the transcutaneous analyte sensor, wherein the processing comprises applying the calibration equation to the data derived at least in part from the transcutaneous analyte sensor to calculate at least one analyte concentration.
20. The method of claim 19 further comprising displaying the processed data on a display device.
21. The method of claim 20 wherein the at least one processor is a processor of the display device.
22. The method of claim 19 wherein the calibration equation is based at least in part on converting an in vitro sensitivity associated with the transcutaneous analyte sensor to an in vivo sensitivity associated with the transcutaneous analyte sensor and wherein the calibration equation compensates for a drift in the in vivo sensitivity associated with the transcutaneous analyte sensor.
23. The method of claim 19 further comprising:
receiving, by the at least one processor, a calibration code; and
determining the factor or the calibration equation based on the received calibration code.
24. The method of claim 19 wherein the measured characteristic of the membrane is a thickness of the membrane of the transcutaneous analyte sensor.
25. A method of monitoring an analyte, the method comprising:
beginning a sensor session associated with use of a transcutaneous analyte sensor, wherein the transcutaneous analyte sensor comprises:
an ex vivo portion configured to remain outside of a body of a host; and
an in vivo portion, wherein the in vivo portion comprises:
an electrode; and
a membrane disposed over at least a portion of the electrode;
storing a factor associated with the transcutaneous analyte sensor in a memory, the factor determined at least in part on a comparison between a measured membrane characteristic of the transcutaneous analyte sensor and a membrane characteristic of at least one other analyte sensor; and
processing, using at least one processor, data derived at least in part from the transcutaneous analyte sensor, wherein the processing comprises using the factor to calculate at least one analyte concentration based on data derived at least in part from the transcutaneous analyte sensor.
26. The method of claim 25 wherein the processing further comprises using a conversion function for calibrating the data derived at least in part from the transcutaneous analyte sensor, the conversion function using the factor,
wherein the conversion function is based at least in part on a predictive relationship between an in vitro sensitivity of the transcutaneous analyte sensor and an in vivo sensitivity of the transcutaneous analyte sensor.
27. The method of claim 26 wherein the conversion function compensates for a drift in the in vivo sensitivity of the transcutaneous analyte sensor.
28. The Method of claim 25 wherein the at least one processor is a single processor that is either physically connected with the transcutaneous analyte sensor or wirelessly connected with the transcutaneous analyte sensor.
29. The method of claim 25 wherein the calculating the at least one analyte concentration does not require a reference analyte data obtained after insertion of the transcutaneous analyte sensor into the body of the host.
30. The method of claim 25 wherein the measured membrane characteristic is a thickness of the membrane of the transcutaneous analyte sensor.